Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-237-5 | CAS number: 10099-58-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented publication which meets basic scientific principles.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 992
Materials and methods
- Principles of method if other than guideline:
- The biological effects and metabolic behaviors of lanthanum were studied by instilling lanthanum chloride intratracheally into male rats.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Details on test material:
- - Name of test material (as cited in study report): lanthanum chloride (Wako Pure Chemicals Co., Osaka, Japan)
- Analytical purity: 99.9%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Clea Japan Co., Tokyo, Japn
- Age at study initiation: 9-11 weeks old
- Weight at study initiation: 252 - 303 g
- Diet (ad libitum): commercial rat chow
- Water (ad libitum): distilled water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 50
Administration / exposure
- Route of administration:
- other: intratracheal
- Vehicle:
- physiological saline
- Doses:
- first group: 0.4 mL of lanthanum chloride solution at doses of 0.5, 1, 10, 20, 50, 100 and 200 µg La/rat
second group: 0.4 mL of lanthanum chloride solution at a dose of 50 µg La/rat - No. of animals per sex per dose:
- first group: 4 male animals per dose
second group: 4 male animals per time point (56 animals, time points: 3, 6, 12 and 24 hours and 2, 3, 5, 7, 14, 21, 28, 56, 84 or 168 days) - Control animals:
- yes
- Details on study design:
- See any other information on materials and methods.
- Statistics:
- Data are presented as means ± SEM. Statistical analysis was performed by Dunnett´s test using the GLM procedure in SAS to compare the mean values between the control and exposed groups. A p-value < 0.05 was considered statistically significant.
Results and discussion
Any other information on results incl. tables
The Lanthanum content showed linear increases with doses of Lanthanum chloride in the lung (lung tissue + BALF) and lung tissue, while the contents in the supernatant and cellular fractions of BALF started to decrease after attaining peak values at a dose of 50 µg La/rat. This indicates that doses of Lanthanum higher than 50 µg were metabolised differently from the metal administered at lower doses. Therefore, a time course study (second exposure group) of the Lanthanum content was performed by administering Lanthanum chloride at a dose level of 50 µg Lanthanum/rat. The animals were sacrificed 3, 6, 12 and 24 hours and 2, 3, 5, 7, 14, 21, 28, 56, 84 or 168 days after instillation.
The biological half-time of Lanthanum in the lung was calculated to be 244 days when Lanthanum chloride was introduced intratracheally into rats at a dose level of 50 µg Lanthanum/rat. Lanthanum in the supernatant fraction of BALF decreased with time and was not detectable after 21 days. In contrast, Lanthanum increased with time in the pellet fraction of BALF up to 5 days post-administration and then leveled off.
Although Lanthanum was given as a soluble salt, the form accumulating mostly in the lung tissue was deposited in insoluble form. A marginally detectable amount was extracted into the supernatant fraction after 1 week. Lanthanum was not detectable in any femur samples from both the time-course and dose-related experiments in the study. Lanthanum was detected marginally in the liver and kidney samples from rats receiving lanthanum chloride at doses of 100 and 200 µg Lanthanum/rat in the dose-related study and after 168 days in the time-course study. At high concentrations, Lanthanum was also detected in the pulmonary hilum lymph nodes.
The numbers of macrophages and polymorphonuclear leukocytes increased in BALF in a dose-related manner up to 100 µg lanthanum/rat and then leveled off. Although eosinophils were marginally detectable in the control BALF, the number started to increase at a dose higher than 50 µg Lanthanum/rat, and was significantly higher at 200 µg Lanthanum/rat.
In alveolar macrophages, many high electron-dense granular inclusions were detected in the lysosomes and cytoplasma. High electron-dense layers were detected on the surface and in the basement membrane of type I pneumocytes. X-ray microanalysis shows that the inclusions and layers contained lanthanum.
In conclusion, Lanthanum was detected in alveolar macrophages as high electron-dense inclusions in lysomsomes and cytoplasm. Lanthanum was also detected in type I pneumocytes as a high electron-dense layer, probably in the basement membrane and on the cell surface. These results would explain the long half-time of lanthanum. Further, the detection of high lanthanum content in pulmonary lymph nodes (qualitative experiment) suggests that lanthanum is partly cleared from the lung through the lymph nodes.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
ECHA har meget materiale online på dit sprog, men en del af det er kun på engelsk. Læs mere om ECHA’s flersprogspolitik.
Velkommen til ECHA's websted. Webstedet understøtter ikke fuldt ud Internet Explorer 7 (og tidligere udgaver). Du skal opgradere din Internet Explorer til en nyere udgave.
Dette websted anvender cookies for at sikre dig den bedste brugeroplevelse.
Få mere at vide om, hvordan vi anvender cookies.